Clinical Trials Logo

Clinical Trial Summary

This study will follow 1000 refugee infants from birth for two years. The aim of the study is to better understand why some children develop infections caused by the bacterium Streptococcus pneumoniae whilst others merely carry this organism asymptomatically at the back of the nose (in the nasopharynx). The investigators will also define which micro-organisms cause lower respiratory tract infections (e.g., pneumonia) in this population in order to implement appropriate interventions (e.g., vaccines). Infants will be reviewed monthly and a nasopharyngeal swab will be taken. A group of 250 mother-infant pairs will be studied in greater detail, to improve our understanding of the frequency and outcomes of nasopharyngeal carriage of Streptococcus pneumoniae. Monthly nasopharyngeal swabs will be collected from mothers and infants. The investigators will measure the infant immune response to Streptococcus pneumoniae carriage or disease by taking monthly blood samples. The investigators will make an assessment of the protective effect of antibodies acquired from the mother during pregnancy by taking blood from the mother and placenta at birth. An assessment of pneumococcal carriage in mothers will also be made to determine how frequently the bacterium is transmitted between family members. All lower respiratory tract infections will be documented, and the causative micro-organisms identified.


Clinical Trial Description

This project's central hypothesis is that acute lower respiratory infections (ALRI) are a common and significant cause of morbidity and mortality in young children living in Maela refugee camp on the Thai-Burmese border, and that this is reflective of the general situation in the developing world. Therefore, we aim to define the incidence, aetiology, and outcome of acute lower respiratory infections in this population. This will focus on Streptococcus pneumoniae and the factors associated with colonisation and invasive disease.

Additional objectives are to:

1. Characterise the interaction between bacterial and viral pathogens and disease.

2. Examine the dynamics of pneumococcal nasopharyngeal carriage, including transmission of strains between infants and their mothers.

3. Determine the effect of the non-pathogenic members of the nasopharyngeal flora on colonisation with potential pathogens.

4. Examine the role of passively transferred maternal pneumococcal antibodies in subsequent pneumococcal colonisation and disease in the infant.

5. Document the development of pneumococcal antibodies in the infants over time and correlate these with pneumococcal carriage and infection episodes.

6. Determine the risk factors associated with respiratory infection.

7. Characterise the bacteria causing invasive non-respiratory infections.

8. Conduct surveillance for influenza and in particular avian influenza A (H5N1) infection. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00894764
Study type Observational
Source University of Oxford
Contact
Status Completed
Phase N/A
Start date September 2007
Completion date April 2012

See also
  Status Clinical Trial Phase
Completed NCT01345695 - Bihar Evaluation of Social Franchising and Telemedicine N/A
Completed NCT03784274 - Pneumonia Policy Formation in Pakistan
Completed NCT03869099 - Pneumonia Case Management Practices in Pakistan
Completed NCT03613636 - Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)
Completed NCT00933049 - Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months Phase 3
Completed NCT03959956 - Improving Paediatric Pneumonia Diagnosis Using Digital Auscultation
Completed NCT03594279 - Community Mobilization and Incentivization for Childhood Diarrhea and Pneumonia N/A
Recruiting NCT03750747 - Assessing the Feasibility and Effectiveness of Introducing Pulse Oximetry in IMCI Services N/A
Completed NCT04495361 - Online Learning Portal on Under Five Pneumonia N/A
Completed NCT04493047 - mHealth for Pneumonia Prevention N/A